Article(id=1329905712571986042, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905658993947118, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.07.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1741536000000, receivedDateStr=2025-03-10, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003830330, onlineDateStr=2026-11-18, pubDate=1752076800000, pubDateStr=2025-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003830330, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003830330, creator=13701087609, updateTime=1795003830330, updator=13701087609, issue=Issue{id=1329905658993947118, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='7', pageStart='837', pageEnd='974', issueExtLink='null', onlineDate='null', pubDate='1752076800000', pubDateStr='2025-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003817556, creator='13701087609', updateTime=1795004375614, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329908000552235556, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905658993947118, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329908000556429861, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905658993947118, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=956, endPage=964, ext={EN=ArticleExt(id=1329905712773312636, articleId=1329905712571986042, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Concerns about Quality Study and Specification of Oral Suspensions, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Jili SHEN, Zhidong WANG, Meng FU, Xinfang ZHANG*, authorsList=Jili SHEN, Zhidong WANG, Meng FU, Xinfang ZHANG, authorCompany=null, correspAuthors=Xinfang ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905713268240509, articleId=1329905712571986042, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=口服混悬剂质量研究与标准制定的关注点, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

口服混悬剂是为吞咽困难患者设计的一种非均相液体制剂,较其他口服制剂加入了更多种类的功能性辅料来维持体系的稳定性及适口性,故其质量研究与控制难度大、潜在的安全性风险高。文章通过调研不同药品监管机构规定、指导原则、药典等文件并结合药品审评经验,全面阐述如何开展该剂型的质量研究与控制,强调了易被忽略的问题,以期为业界开发高质量的口服混悬剂提供参考。

, authors=申际丽, 王志东, 付盟, 张新房*, authorsList=申际丽, 王志东, 付盟, 张新房, authorCompany=null, correspAuthors=张新房, authorNote=

申际丽,女,硕士,审评员,从事化药药学的技术审评工作。

, correspAuthorsNote=
张新房,男,副主任药师,主审审评员,从事化药药学的技术审评工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=6+pfmw5HqYIUMQDc9miXBg==, magXml=Kd2DoINkNBEYvRhP3gtjpg==, pdfUrl=null, pdf=GB847uDvxZt8N/y7zOr2Yg==, pdfFileSize=1000149, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=LoERfJmqB12GUeDJa7x+pQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329905713687670914, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905713788334212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713687670914, language=EN, stringName=Jili SHEN, firstName=Jili, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905713851248773, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713687670914, language=CN, stringName=申际丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

申际丽,女,硕士,审评员,从事化药药学的技术审评工作。

"}, bioImg=null, bioContent=

申际丽,女,硕士,审评员,从事化药药学的技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1329905713926746247, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905714010632329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713926746247, language=EN, stringName=Zhidong WANG, firstName=Zhidong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905714111295626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713926746247, language=CN, stringName=王志东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1329905714186793100, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905714283262094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714186793100, language=EN, stringName=Meng FU, firstName=Meng, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905714354565263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714186793100, language=CN, stringName=付盟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1329905714413285521, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangxf@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905714513948819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714413285521, language=EN, stringName=Xinfang ZHANG, firstName=Xinfang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905714581057684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714413285521, language=CN, stringName=张新房, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1329905714694303893, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, language=CN, orderNo=1, keyword=口服混悬液), Keyword(id=1329905714799161494, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, language=CN, orderNo=2, keyword=口服干混悬剂), Keyword(id=1329905714895630487, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, language=CN, orderNo=3, keyword=质量标准), Keyword(id=1329905714962739352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, language=CN, orderNo=4, keyword=溶出), Keyword(id=1329905715059208345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, language=CN, orderNo=5, keyword=稳定性)], refs=[Reference(id=1329905715134705818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO.Draft working document for comments: development of paediatric medicines points to consider in formulation[EB/OL].[2025-03-10].https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/qas24.950_paediatric_medicines.pdf?sfvrsn=59fed2f_1., articleTitle=null, refAbstract=null), Reference(id=1329905715206008987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Oral solutions and suspensions (8/94). Guide to inspections oral solutions and suspensions [EB/OL].(2014-11-17)[2025-03-10].https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/oral-solutions-and-suspensions-894, articleTitle=null, refAbstract=null), Reference(id=1329905715277312156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.Q6A质量标准:新原料药和新药制剂的检测方法和可接受标准: 化学药物[EB/OL].(1999-10-06)[2025-03-10].https://www.cde.org.cn/ichWeb/guideIch/toGuideIch/1/0., articleTitle=null, refAbstract=null), Reference(id=1329905715352809629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.儿童用药(化学药品)药学开发指导原则(试行)[EB/OL].(2020-12-31)[2025-03-10].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=b24aa57426796f1624dff698b233ba05., articleTitle=null, refAbstract=null), Reference(id=1329905715436695710, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Nasal spray and inhalation solution, suspension,and spray drug products —chemistry, manufacturing, and controls documentation [EB/OL].[2025-03-10].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/nasal-spray-and-inhalation-solution-suspension-and-spray-drug-products-chemistry-manufacturing-and., articleTitle=null, refAbstract=null), Reference(id=1329905715507998879, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.Q2(R2):分析方法验证 [EB/OL].(2023-11-01)[2025-06-20].https://www.cde.org.cn/ichWeb/guideIch/toGuideIch/1/0., articleTitle=null, refAbstract=null), Reference(id=1329905715562524832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Note for guidance on excipients, antioxidants andantimicrobial preservatives in the dossier forapplication for marketing authorisation of amedicinal product [EB/OL].(2003-02-20)[2025-03-10].https://www.ema.europa.eu/en/documents/scientific-guideline/draft-note-guidance-excipients-antioxidants-antimicrobial-preservatives-dossier-application_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1329905715629633697, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Tamiflu: EPAR-scientific discussion [EB/OL].(2005-10-21)[2025-06-20].https://www.ema.europa.eu/en/documents/scientific-discussion/tamiflu-epar-scientific-discussion_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1329905715692548258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=MAHESWARAN R.FDA Perspectives: scientific considerations offorced degradation studies in ANDA submissions [J].Pharm Tech, 2012, 36(5): 73-80., articleTitle=null, refAbstract=null), Reference(id=1329905715751268515, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.M7: 评估和控制药物中的DNA反应性(致突变)杂质以限制潜在致癌风险 [EB/OL].(2023-04-03)[2025-05-10].https://www.cde.org.cn/ichWeb/guideIch/toGuideIch/4/0., articleTitle=null, refAbstract=null), Reference(id=1329905715805794468, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Compilation of FDA guidance and resources for in vitro dissolution testing of immediate release solid oral dosage forms [EB/OL].(2025-02-20)[2025-03-10].https://www.fda.gov/animal-veterinary/new-animal-drug-applications/compilation-fda-guidance-and-resources-in-vitro-dissolution-testing-immediate-release-solid-oral-dosage., articleTitle=null, refAbstract=null), Reference(id=1329905715889680549, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.M9: Biopharmaceutics classification system-based biowaivers and Q&As on biopharmaceutics classification system-based biowaivers [EB/OL].(2019-11-20)[2025-03-10].https://www.ich.org/page/multidisciplinary-guidelines., articleTitle=null, refAbstract=null), Reference(id=1329905715944206502, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ANAND O, YU L X, CONNER D P, et al.Dissolution testing for generic drugs an FDA perspective [J].AAPS J,2011, 13(3): 328-335., articleTitle=null, refAbstract=null), Reference(id=1329905716049064103, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SIEWERT M, DRESSMAN J, BROWN C K, et al.FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms [J].AAPS PharmSciTech, 2003, 4., articleTitle=null, refAbstract=null), Reference(id=1329905716116172968, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Specific product guidance: draft guidance on posaconazole oral suspension [EB/OL].[2025-03-10].https://www.https://www.accessdata.fda.gov/drugsatfda_docs/psg/Posaconazole_Susp_22003_RC11-07.pdf., articleTitle=null, refAbstract=null), Reference(id=1329905716183281833, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Specific product guidance: methylphenidate hydrochloride_draft_oral suspension [EB/OL].[2025-03-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Methylphenidate%20Hydrochloride_draft_Oral%20suspER_RLD%20202100_RC12-14.pdf., articleTitle=null, refAbstract=null), Reference(id=1329905716262973610, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药共性问题“口服多剂量包装干混悬剂溶出度、溶出曲线研究时供试品该如何取样?” [EB/OL].(2025-05-23)[2025-06-20].https://www.cde.org.cn/main/xxgk/listpage/07edef25f1e7354bfd8490baa0ce056b., articleTitle=null, refAbstract=null), Reference(id=1329905716334276779, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO.QAS_Dissolution_test_for_solid_oral_dosage_forms[EB/OL].(2020-06)[2025-03-10].https://www.who.int/docs/default-source/medicines/norms-and-standards/current-projects/qas20-837-dissolution-test-for-solid-oral-dosage-forms.pdf., articleTitle=null, refAbstract=null), Reference(id=1329905716401385644, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药共性问题“多剂量包装干混悬剂的溶出度、溶出曲线试验投样量该如何确定?”[EB/OL].(2025-05-23)[2025-06-20].https://www.cde.org.cn/main/xxgk/listpage/07edef25f1e7354bfd8490baa0ce056b., articleTitle=null, refAbstract=null), Reference(id=1329905716460105902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药共性问题“口服多剂量包装干混悬剂的溶出度、溶出曲线试验投样方式应选择“固体(粉末/颗粒)形式”还是“混悬液形式?”[EB/OL].(2025-05-23)[2025-06-20].https://www.cde.org.cn/main/xxgk/listpage/07edef25f1e7354bfd8490baa0ce056b., articleTitle=null, refAbstract=null), Reference(id=1329905716531409071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Reflection paper on the dissolution specification for generic-solid oral immediate release products with systemic action[EB/OL].(2017-07)[2025-03-10].https://www.tga.gov.au/resources/resource/international-scientific-guidelines/reflection-paper-dissolution-specification-generic-solid-oral-immediate-release-products-systemic-action#:~:text=Reflection-paper-on-the-dissolution-specification-for-generic-solid-oral-immediate-release-products-with-systemic-action%20%5BPDF%2C%20156.9%20KB%5D%20Adopted,by%20the%20TGA%3A%208%20June%202023., articleTitle=null, refAbstract=null), Reference(id=1329905716644655280, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Dissolution methods database frequently asked questions [EB/OL].(2022-03-01)[2025-06-20].https://www.fda.gov/drugs/development-resources/dissolution-methods-database-frequently-asked-questions#7., articleTitle=null, refAbstract=null), Reference(id=1329905716724347057, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=申际丽, 龚 青, 张新房.儿童用药中使用抑菌剂时的关注点及注册申报要求[J].中国医药工业杂志, 2022,53(11): 1599-1605., articleTitle=null, refAbstract=null), Reference(id=1329905716812427442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.LRB QbR for oral solutions and suspensions [EB/OL].(2021-05-06)[2025-03-10].https://www.fda.gov/drugs/how-drugs-are-developed-and-approved/lrb-qbr-oral-solutions-and-suspensions., articleTitle=null, refAbstract=null), Reference(id=1329905716908896435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药晶型研究技术指导原则(试行) [EB/OL].(2023-03-21)[2025-03-10].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=9c628f356cbaa79302e2d8149c187ec2., articleTitle=null, refAbstract=null), Reference(id=1329905716992782516, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.非无菌化学药品及原辅料微生物限度研究技术指导原则(试行)[EB/OL].(2023-02-21)[2025-03-10].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=cd40042c3b58ca4f20eea30893fe23d7., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.07.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.07.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.07.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.07.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1752076800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
口服混悬剂质量研究与标准制定的关注点
申际丽 , 王志东 , 付盟 , 张新房 *
中国医药工业杂志 | 药学管理与信息 2025,56(7): 956-964
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2025 , 56 (7) : 956 -964
口服混悬剂质量研究与标准制定的关注点
全屏
[Author(id=1329905713687670914, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905713788334212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713687670914, language=EN, stringName=Jili SHEN, firstName=Jili, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905713851248773, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713687670914, language=CN, stringName=申际丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

申际丽,女,硕士,审评员,从事化药药学的技术审评工作。

"}, bioImg=null, bioContent=

申际丽,女,硕士,审评员,从事化药药学的技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1329905713926746247, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905714010632329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713926746247, language=EN, stringName=Zhidong WANG, firstName=Zhidong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905714111295626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905713926746247, language=CN, stringName=王志东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1329905714186793100, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905714283262094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714186793100, language=EN, stringName=Meng FU, firstName=Meng, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905714354565263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714186793100, language=CN, stringName=付盟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1329905714413285521, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangxf@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905714513948819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714413285521, language=EN, stringName=Xinfang ZHANG, firstName=Xinfang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905714581057684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, authorId=1329905714413285521, language=CN, stringName=张新房, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905713566036094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, xref=null, ext=[AuthorCompanyExt(id=1329905713578619007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1329905713616367744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905712571986042, companyId=1329905713566036094, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])]
申际丽, 王志东, 付盟, 张新房*
作者信息
  • 国家药品监督管理局药品审评中心,北京 100022
通讯作者:
张新房,男,副主任药师,主审审评员,从事化药药学的技术审评工作。E-mail:
作者简介:

申际丽,女,硕士,审评员,从事化药药学的技术审评工作。

Concerns about Quality Study and Specification of Oral Suspensions
Jili SHEN, Zhidong WANG, Meng FU, Xinfang ZHANG*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
出版时间: 2025-07-10 doi: 10.16522/j.cnki.cjph.2025.07.016
文章导航
收藏切换

口服混悬剂是为吞咽困难患者设计的一种非均相液体制剂,较其他口服制剂加入了更多种类的功能性辅料来维持体系的稳定性及适口性,故其质量研究与控制难度大、潜在的安全性风险高。文章通过调研不同药品监管机构规定、指导原则、药典等文件并结合药品审评经验,全面阐述如何开展该剂型的质量研究与控制,强调了易被忽略的问题,以期为业界开发高质量的口服混悬剂提供参考。

口服混悬液  /  口服干混悬剂  /  质量标准  /  溶出  /  稳定性
申际丽, 王志东, 付盟, 张新房. 口服混悬剂质量研究与标准制定的关注点. 中国医药工业杂志, 2025 , 56 (7) : 956 -964 . DOI: 10.16522/j.cnki.cjph.2025.07.016
Jili SHEN, Zhidong WANG, Meng FU, Xinfang ZHANG. Concerns about Quality Study and Specification of Oral Suspensions[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (7) : 956 -964 . DOI: 10.16522/j.cnki.cjph.2025.07.016

参考文献 引证文献
排序方式:
[1]
WHO.Draft working document for comments: development of paediatric medicines points to consider in formulation[EB/OL].[2025-03-10].https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/qas24.950_paediatric_medicines.pdf?sfvrsn=59fed2f_1.
[2]
FDA.Oral solutions and suspensions (8/94). Guide to inspections oral solutions and suspensions [EB/OL].(2014-11-17)[2025-03-10].https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/oral-solutions-and-suspensions-894
[3]
ICH.Q6A质量标准:新原料药和新药制剂的检测方法和可接受标准: 化学药物[EB/OL].(1999-10-06)[2025-03-10].https://www.cde.org.cn/ichWeb/guideIch/toGuideIch/1/0.
[4]
国家药品监督管理局药品审评中心.儿童用药(化学药品)药学开发指导原则(试行)[EB/OL].(2020-12-31)[2025-03-10].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=b24aa57426796f1624dff698b233ba05.
[5]
FDA.Nasal spray and inhalation solution, suspension,and spray drug products —chemistry, manufacturing, and controls documentation [EB/OL].[2025-03-10].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/nasal-spray-and-inhalation-solution-suspension-and-spray-drug-products-chemistry-manufacturing-and.
[6]
ICH.Q2(R2):分析方法验证 [EB/OL].(2023-11-01)[2025-06-20].https://www.cde.org.cn/ichWeb/guideIch/toGuideIch/1/0.
[7]
EMA.Note for guidance on excipients, antioxidants andantimicrobial preservatives in the dossier forapplication for marketing authorisation of amedicinal product [EB/OL].(2003-02-20)[2025-03-10].https://www.ema.europa.eu/en/documents/scientific-guideline/draft-note-guidance-excipients-antioxidants-antimicrobial-preservatives-dossier-application_en.pdf.
[8]
EMA.Tamiflu: EPAR-scientific discussion [EB/OL].(2005-10-21)[2025-06-20].https://www.ema.europa.eu/en/documents/scientific-discussion/tamiflu-epar-scientific-discussion_en.pdf.
[9]
MAHESWARAN R.FDA Perspectives: scientific considerations offorced degradation studies in ANDA submissions [J].Pharm Tech, 2012, 36(5): 73-80.
[10]
ICH.M7: 评估和控制药物中的DNA反应性(致突变)杂质以限制潜在致癌风险 [EB/OL].(2023-04-03)[2025-05-10].https://www.cde.org.cn/ichWeb/guideIch/toGuideIch/4/0.
[11]
FDA.Compilation of FDA guidance and resources for in vitro dissolution testing of immediate release solid oral dosage forms [EB/OL].(2025-02-20)[2025-03-10].https://www.fda.gov/animal-veterinary/new-animal-drug-applications/compilation-fda-guidance-and-resources-in-vitro-dissolution-testing-immediate-release-solid-oral-dosage.
[12]
ICH.M9: Biopharmaceutics classification system-based biowaivers and Q&As on biopharmaceutics classification system-based biowaivers [EB/OL].(2019-11-20)[2025-03-10].https://www.ich.org/page/multidisciplinary-guidelines.
[13]
ANAND O, YU L X, CONNER D P, et al.Dissolution testing for generic drugs an FDA perspective [J].AAPS J,2011, 13(3): 328-335.
[14]
SIEWERT M, DRESSMAN J, BROWN C K, et al.FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms [J].AAPS PharmSciTech, 2003, 4.
[15]
FDA.Specific product guidance: draft guidance on posaconazole oral suspension [EB/OL].[2025-03-10].https://www.https://www.accessdata.fda.gov/drugsatfda_docs/psg/Posaconazole_Susp_22003_RC11-07.pdf.
[16]
FDA.Specific product guidance: methylphenidate hydrochloride_draft_oral suspension [EB/OL].[2025-03-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Methylphenidate%20Hydrochloride_draft_Oral%20suspER_RLD%20202100_RC12-14.pdf.
[17]
国家药品监督管理局药品审评中心.化学仿制药共性问题“口服多剂量包装干混悬剂溶出度、溶出曲线研究时供试品该如何取样?” [EB/OL].(2025-05-23)[2025-06-20].https://www.cde.org.cn/main/xxgk/listpage/07edef25f1e7354bfd8490baa0ce056b.
[18]
WHO.QAS_Dissolution_test_for_solid_oral_dosage_forms[EB/OL].(2020-06)[2025-03-10].https://www.who.int/docs/default-source/medicines/norms-and-standards/current-projects/qas20-837-dissolution-test-for-solid-oral-dosage-forms.pdf.
[19]
国家药品监督管理局药品审评中心.化学仿制药共性问题“多剂量包装干混悬剂的溶出度、溶出曲线试验投样量该如何确定?”[EB/OL].(2025-05-23)[2025-06-20].https://www.cde.org.cn/main/xxgk/listpage/07edef25f1e7354bfd8490baa0ce056b.
[20]
国家药品监督管理局药品审评中心.化学仿制药共性问题“口服多剂量包装干混悬剂的溶出度、溶出曲线试验投样方式应选择“固体(粉末/颗粒)形式”还是“混悬液形式?”[EB/OL].(2025-05-23)[2025-06-20].https://www.cde.org.cn/main/xxgk/listpage/07edef25f1e7354bfd8490baa0ce056b.
[21]
EMA.Reflection paper on the dissolution specification for generic-solid oral immediate release products with systemic action[EB/OL].(2017-07)[2025-03-10].https://www.tga.gov.au/resources/resource/international-scientific-guidelines/reflection-paper-dissolution-specification-generic-solid-oral-immediate-release-products-systemic-action#:~:text=Reflection-paper-on-the-dissolution-specification-for-generic-solid-oral-immediate-release-products-with-systemic-action%20%5BPDF%2C%20156.9%20KB%5D%20Adopted,by%20the%20TGA%3A%208%20June%202023.
[22]
FDA.Dissolution methods database frequently asked questions [EB/OL].(2022-03-01)[2025-06-20].https://www.fda.gov/drugs/development-resources/dissolution-methods-database-frequently-asked-questions#7.
[23]
申际丽, 龚 青, 张新房.儿童用药中使用抑菌剂时的关注点及注册申报要求[J].中国医药工业杂志, 2022,53(11): 1599-1605.
[24]
FDA.LRB QbR for oral solutions and suspensions [EB/OL].(2021-05-06)[2025-03-10].https://www.fda.gov/drugs/how-drugs-are-developed-and-approved/lrb-qbr-oral-solutions-and-suspensions.
[25]
国家药品监督管理局药品审评中心.化学仿制药晶型研究技术指导原则(试行) [EB/OL].(2023-03-21)[2025-03-10].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=9c628f356cbaa79302e2d8149c187ec2.
[26]
国家药品监督管理局药品审评中心.非无菌化学药品及原辅料微生物限度研究技术指导原则(试行)[EB/OL].(2023-02-21)[2025-03-10].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=cd40042c3b58ca4f20eea30893fe23d7.
2025年第56卷第7期
21
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.07.016
  • 接收时间:2025-03-10
  • 首发时间:2026-11-18
  • 出版时间:2025-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-03-10
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100022

通讯作者:

张新房,男,副主任药师,主审审评员,从事化药药学的技术审评工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.07.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏